News & events
Learn more about Angiex in latest news posts and press releases, events & presentations, and discover Angiex's presence in the media.
Latest news
Press release
14 November 2025
Press release
07 August 2024
In the media
11 October 2024
How to Build Your Biotech Company in 2024 (According to Founders)
Angiex was featured as one of a select few companies in Labiotech’s article on building successful biotech startups. CEO Paul Jaminet shared insights on the advantages of Cambridge’s biotech ecosystem.
07 October 2024
North American Biotech Innovation: Who and Where?
Angiex is featured in Drug Discovery World as a leading North American biotech innovator. CEO Paul Jaminet discusses the critical role of Cambridge’s infrastructure in the company’s early success and its development of TM4SF1-directed ADCs.
15 August 2024
Abzena Supplies Clinical Trial Material for Angiex's Phase I Study Of AGX101, A First-In-Class TM4SF1-Directed ADC
Angiex doses the first patient in its Phase 1 trial of a novel antibody-drug conjugate (ADC) therapy targeting blood vessels in tumors, marking a significant milestone in cancer treatment development